Risperidone has been primarily marketed for the treatment of schizophrenia.
There are reports about its potential role for the treatment of affective
illness. We report here another case of a patient with psychotic depression
who was treated successfully with risperidone as monotherapy. This case re
port suggests that risperidone can be an efficient treatment mode for psych
otic depression; however, it needs more data based on controlled study.